The Global Fund and partners began deploying PlusLife MiniDock Ultra near point-of-care TB test systems across 13 countries, supported by $50 million from the Children’s Investment Fund Foundation. The rollout is designed to expand testing capacity where traditional lab infrastructure can be limited. PlusLife’s MiniDock Ultra system is intended for decentralized use, aligning with global efforts to shorten time to diagnosis and improve linkage to treatment. The financing signals sustained donor interest in point-of-care technologies as a mechanism to reduce delays in TB detection. The deployment plan covers multiple geographies from the start, with coordination efforts involving the Global Fund’s country and implementation stakeholders.